163 related articles for article (PubMed ID: 37857565)
21. Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Xu T; Hu C; Zhu G; He X; Wu Y; Ying H
Med Oncol; 2012 Mar; 29(1):272-8. PubMed ID: 21279704
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.
Yao JJ; Yu XL; Zhang F; Zhang WJ; Zhou GQ; Tang LL; Mao YP; Chen L; Ma J; Sun Y
Chin J Cancer; 2017 Mar; 36(1):26. PubMed ID: 28264724
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
[TBL] [Abstract][Full Text] [Related]
25. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.
Lan M; Chen C; Huang Y; Tian L; Duan Z; Han F; Liao J; Deng M; Sio TT; Prayongrat A; Zheng L; Wu S; Lu T
Sci Rep; 2017 Feb; 7():42624. PubMed ID: 28211482
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer.
Yu XL; Wu MF; Ding L; Yang J; Bai SM
Cancer Manag Res; 2021; 13():9297-9304. PubMed ID: 35221720
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
[TBL] [Abstract][Full Text] [Related]
31. Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study.
Benson R; Pathy S; Kumar L; Mathur S; Dadhwal V; Mohanti BK
J Cancer Res Ther; 2019; 15(6):1359-1364. PubMed ID: 31898673
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
34. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
35. Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin.
Arakaki Y; Ariga T; Heianna J; Shimoji Y; Nakasone T; Taira Y; Nakamoto T; Ooyama T; Kudaka W; Kaneshima I; Nishihira K; Mekaru K; Aoki Y
In Vivo; 2020; 34(5):2739-2743. PubMed ID: 32871808
[TBL] [Abstract][Full Text] [Related]
36. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
37. Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma.
Lin Y; Yu X; Lu L; Chen H; Wu J; Chen Y; Lin Q; Wang X; Chen X; Chen X
Cancer Biomark; 2023; 37(1):1-11. PubMed ID: 36938724
[TBL] [Abstract][Full Text] [Related]
38. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
39. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
Ditto A; Longo M; Chiarello G; Mariani L; Paolini B; Leone Roberti Maggiore U; Martinelli F; Bogani G; Raspagliesi F
Eur J Surg Oncol; 2024 Jun; 50(6):108311. PubMed ID: 38554552
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]